Madhu Sharma

578 total citations
36 papers, 395 citations indexed

About

Madhu Sharma is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Madhu Sharma has authored 36 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Biomaterials and 9 papers in Biomedical Engineering. Recurrent topics in Madhu Sharma's work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Single-cell and spatial transcriptomics (2 papers). Madhu Sharma is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Single-cell and spatial transcriptomics (2 papers). Madhu Sharma collaborates with scholars based in India, Türkiye and Saudi Arabia. Madhu Sharma's co-authors include Prabhat Ranjan Mishra, Disha Marwaha, Shalini Gautam, Ravi Prakash Shukla, Pratiksha Tiwari, Venkatesh Teja Banala, Sandeep Urandur, Nikhil Rai, Krishna Yadav and Shweta Sharma and has published in prestigious journals such as Journal of Controlled Release, Genome Research and Acta Biomaterialia.

In The Last Decade

Madhu Sharma

31 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madhu Sharma India 12 173 112 93 55 45 36 395
Nirnoy Dan United States 7 139 0.8× 116 1.0× 100 1.1× 67 1.2× 30 0.7× 9 376
Nikhil Rai India 11 149 0.9× 122 1.1× 117 1.3× 53 1.0× 51 1.1× 21 359
Disha Marwaha India 11 201 1.2× 138 1.2× 141 1.5× 63 1.1× 63 1.4× 18 427
Eun Hyang Jang South Korea 14 179 1.0× 112 1.0× 83 0.9× 51 0.9× 46 1.0× 17 388
Kaipei Luo China 11 147 0.8× 119 1.1× 103 1.1× 50 0.9× 25 0.6× 15 354
Xiaoya Hou China 9 132 0.8× 129 1.2× 114 1.2× 35 0.6× 47 1.0× 10 401
Yifan Fang China 10 159 0.9× 101 0.9× 121 1.3× 33 0.6× 46 1.0× 27 390
Mahdie Hemati Iran 11 167 1.0× 118 1.1× 90 1.0× 22 0.4× 45 1.0× 25 414
Jianlin Long China 6 167 1.0× 183 1.6× 78 0.8× 38 0.7× 30 0.7× 14 451

Countries citing papers authored by Madhu Sharma

Since Specialization
Citations

This map shows the geographic impact of Madhu Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madhu Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madhu Sharma more than expected).

Fields of papers citing papers by Madhu Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madhu Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madhu Sharma. The network helps show where Madhu Sharma may publish in the future.

Co-authorship network of co-authors of Madhu Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Madhu Sharma. A scholar is included among the top collaborators of Madhu Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madhu Sharma. Madhu Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mishra, Prabhat, Prabhat Mishra, Ankit Kumar, et al.. (2025). Emerging Trends in cervical cancer Treatment: Transitioning from traditional to innovative delivery strategies. International Journal of Pharmaceutics. 681. 125878–125878. 1 indexed citations
3.
Tiwari, Pratiksha, et al.. (2025). YIGSR Functionalized Hybrid Exosomes Spatially Target Dasatinib to Laminin Receptors for Precision Therapy in Breast Cancer. Advanced Healthcare Materials. 14(9). e2402673–e2402673. 1 indexed citations
4.
Sharma, Madhu, Aarti Bains, Gülden Gökşen, et al.. (2024). A review of valorization of agricultural waste for the synthesis of cellulose membranes: Separation of organic, inorganic, and microbial pollutants. International Journal of Biological Macromolecules. 277(Pt 2). 134170–134170. 14 indexed citations
5.
Sharma, Madhu, et al.. (2024). Unveiling micro-nanoplastics (MNPs) induced developmental toxicity, transgenerational transport and associated signaling pathways. Journal of Hazardous Materials Advances. 17. 100581–100581.
6.
Sharma, Madhu, Gülden Gökşen, Nemat Ali, et al.. (2024). Advancing antimicrobial efficacy of Cucumis momordica seeds: Nanoemulsion application in Eurotium cristatum-mediated solid-state fermentation. Food and Bioproducts Processing. 148. 507–518. 1 indexed citations
7.
Marwaha, Disha, Shalini Gautam, Nikhil Rai, et al.. (2024). Pemetrexed-loaded supramolecular acetal-functionalized pH-responsive nanocarriers selectively induce apoptosis through biotin receptors to enhance antitumor efficacy. Colloids and Surfaces B Biointerfaces. 245. 114247–114247. 2 indexed citations
8.
Mishra, Nidhi, Madhu Sharma, Priya Singh, et al.. (2023). Crosslinked and PEGylated Pectin Chitosan nanoparticles for delivery of Phytic acid to colon. International Journal of Pharmaceutics. 639. 122937–122937. 12 indexed citations
9.
Tiwari, Pratiksha, Krishna Yadav, Ravi Prakash Shukla, et al.. (2023). Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy. Journal of Controlled Release. 363. 290–348. 58 indexed citations
11.
Gautam, Shalini, Disha Marwaha, Nikhil Rai, et al.. (2023). Self-Assembled Redox-Sensitive Polymeric Nanostructures Facilitate the Intracellular Delivery of Paclitaxel for Improved Breast Cancer Therapy. Molecular Pharmaceutics. 20(4). 1914–1932. 24 indexed citations
12.
Sharma, Madhu, Pratiksha Tiwari, Ankit Kumar, et al.. (2023). Immobilized doxorubicin and ribociclib carbamate linkers encaged in surface modified cubosomes spatially target tumor reductive environment to enhance antitumor efficacy. Biomaterials Advances. 155. 213672–213672. 7 indexed citations
13.
Marwaha, Disha, Shalini Gautam, Neha Singh, et al.. (2023). Synergistic delivery of Imatinib through multifunctional nano-crystalline capsules, in response to redox environment for improved breast cancer therapy. Colloids and Surfaces B Biointerfaces. 226. 113316–113316. 12 indexed citations
14.
15.
Sharma, Madhu, et al.. (2023). Neuroprotective Efficacy of Fisetin Against VPA-Induced Autistic Neurobehavioral Alterations by Targeting Dysregulated Redox Homeostasis. Journal of Molecular Neuroscience. 73(6). 403–422. 8 indexed citations
17.
18.
Sharma, Madhu, Naresh Mittapelly, Shalini Gautam, et al.. (2022). Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer. Journal of Controlled Release. 346. 43–70. 59 indexed citations
19.
Sharma, Madhu, et al.. (2021). Computational challenges in detection of cancer using cell-free DNA methylation. Computational and Structural Biotechnology Journal. 20. 26–39. 28 indexed citations
20.
Banala, Venkatesh Teja, Sandeep Urandur, Shweta Sharma, et al.. (2019). Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression. Biomaterials Science. 7(7). 2889–2906. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026